|
Session 97
Poster Abstracts
Clinical Pharmacology of Protease Inhibitors
Tuesday, 1:30 - 3:30 pm
Poster Hall |
576
 |
Low Atazanavir Concentrations in Cerebrospinal Fluid
Brookie Best*1, S Letendre1, P Patel1, D Clifford2, A Collier3, B Gelman4, J McArthur5, J McCutchan1, D Simpson6, and E Capparelli1
1Univ of California, San Diego, US; 2Washington Univ, St Louis, MO, US; 3Univ of Washington, Seattle, US; 4Univ of Texas Med Branch, Galveston, US; 5Johns Hopkins Univ, Baltimore, MD, US; and 6Mt Sinai Sch of Med, New York, NY, US |
577
|
Tipranavir Genotypic Inhibitory Quotient Predicts Early Virological Response to TPV-based Salvage Regimens
Stefano Bonora*, D Gonzalez De Requena, A Calcagno, M Milia, A D'Avolio, M Sciandra, S Garazzino, M Siccardi, A Sinicco, and G Di Perri
Univ of Turin, Italy |
578
|
Lack of Effect of Acid-reducing Agents on the Pharmacokinetics of Lopinavir/Ritonavir Tablet
Cheri Klein*1, Y L Chiu1, Y Cai1, K Beck2, K King1, S Causemaker1, T Doan1, H U Esslinger2, T Podsadecki1, and G Hanna1
1Abbott Labs, Abbott Park, IL, US and 2Abbott GmbH & Co KG Ludwigshafen, Germany |
|
